Molecular studies are required to evaluate whether MIF has a protective role in patients with active vitiligo and short evolution trying to regulate the inflammatory response or if MIF is a part of the courtship of pro‐inflammatory cytokines that cause the clinical manifestations. The gene discussed is MIF; the disease is vitiligo.